Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atherosclerosis: cell biology and lipoproteins.

Literature DB >> 24005221

Atherosclerosis: cell biology and lipoproteins.

Hong Lu, Alan Daugherty.

Abstract

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：
Lipoproteins

Year: 2013 PMID： 24005221 PMCID： PMC4382098 DOI： 10.1097/MOL.0b013e3283654ef9

Source DB: PubMed Journal: Curr Opin Lipidol ISSN： 0957-9672 Impact factor: 4.776

× No keyword cloud information.

14 in total

Review 1. Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia.

Authors: Kara N Maxwell; Jan L Breslow
Journal: Curr Opin Lipidol Date: 2005-04 Impact factor: 4.776

2. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.

Authors: Shirya Rashid; David E Curtis; Rita Garuti; Norma N Anderson; Yuriy Bashmakov; Y K Ho; Robert E Hammer; Young-Ah Moon; Jay D Horton
Journal: Proc Natl Acad Sci U S A Date: 2005-04-01 Impact factor: 11.205

3. Induction of atherosclerosis in mice and hamsters without germline genetic engineering.

Authors: Martin Maeng Bjørklund; Anne Kruse Hollensen; Mette Kallestrup Hagensen; Frederik Dagnaes-Hansen; Christina Christoffersen; Jacob Giehm Mikkelsen; Jacob Fog Bentzon
Journal: Circ Res Date: 2014-03-27 Impact factor: 17.367

4. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.

Authors: Yascara Grisel Luna Saavedra; Robert Dufour; Jean Davignon; Alexis Baass
Journal: Arterioscler Thromb Vasc Biol Date: 2014-10-02 Impact factor: 8.311

5. Development of experimental designs for atherosclerosis studies in mice.

Authors: Alan Daugherty; Debra L Rateri
Journal: Methods Date: 2005-06 Impact factor: 3.608

6. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells.

Authors: Florent Lalanne; Gilles Lambert; Marcelo J A Amar; Maud Chétiveaux; Yassine Zaïr; Anne-Laure Jarnoux; Khadija Ouguerram; José Friburg; Nabil G Seidah; H Bryan Brewer; Michel Krempf; Philippe Costet
Journal: J Lipid Res Date: 2005-03-01 Impact factor: 5.922

7. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.

Authors: S Ishibashi; J Herz; N Maeda; J L Goldstein; M S Brown
Journal: Proc Natl Acad Sci U S A Date: 1994-05-10 Impact factor: 11.205

8. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors: Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal: Nat Genet Date: 2003-06 Impact factor: 38.330

9. The proprotein convertase subtilisin/kexin type 9 (PCSK9) active site and cleavage sequence differentially regulate protein secretion from proteolysis.

Authors: John S Chorba; Kevan M Shokat
Journal: J Biol Chem Date: 2014-09-10 Impact factor: 5.157

10. Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).

Authors: Maryssa Canuel; Xiaowei Sun; Marie-Claude Asselin; Eustache Paramithiotis; Annik Prat; Nabil G Seidah
Journal: PLoS One Date: 2013-05-13 Impact factor: 3.240

3 in total